Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01123369 · ClinicalTrials.gov registry record
Spectralis HRA+OCT Imaging of the Retina With Autofluorescence in Sickle Cell Disease
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 8
- Enrollment target
NCT01123369 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 8 participants.
The verdict
NCT01123369 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
To determine the retinal and choroidal thickness in patients with sickle cell disease compared to age, race matched population without sickle cell disease to allow a better understanding of the clinical manifestations of sickle cell retinopathy. The purpose of this research study is to evaluate the relationship between sickle cell disease and the eye. The research study is recruiting African American population with or without Sickle Cell Disease. The investigator in charge of this study is Dr E. Bowie. Approximately 60 subjects of both sexes will be enrolled at the Medical University of South Carolina.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2010-02 |
| Est. Completion | 2010-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01123369
The ClinicalTrials.gov registry entry for NCT01123369 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01123369 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01123369 about?
NCT01123369 is a clinical study titled "Spectralis HRA+OCT Imaging of the Retina With Autofluorescence in Sickle Cell Disease". To determine the retinal and choroidal thickness in patients with sickle cell disease compared to age, race matched population without sickle cell disease to allow a better understanding of the clinical manifestations of sickle cell retinopathy. The purpose of this research study is to evaluate the ...
What is the current status of trial NCT01123369?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2010-02. Estimated completion is 2010-07.
Who is sponsoring clinical trial NCT01123369?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.